Starling Oncology, Inc. (DFPH) Operating cash flow 2020–2025
Starling Oncology, Inc. (DFPH) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$24.6MFY2025 · since FY2020: $508,000 → -$24.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.6M | +7.4% |
| FY2024 | -$26.5M | +26.9% |
| FY2023 | -$36.3M | +41.2% |
| FY2022 | -$61.8M | -89.0% |
| FY2021 | -$32.7M | -6533.1% |
| FY2020 | $508,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DFPH financial trends
DFPH RevenueDFPH Net incomeDFPH Net marginDFPH Gross profitDFPH Gross marginDFPH Operating incomeDFPH Operating marginDFPH Free cash flowDFPH Capital expendituresDFPH Return on equityDFPH Stock buybacksDFPH Dividends paidDFPH Total assetsDFPH Total liabilitiesDFPH Shareholders’ equityDFPH overview →